Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
J Pediatr. 2021 Jun;233:183-190.e3. doi: 10.1016/j.jpeds.2020.12.035. Epub 2021 Jan 26.
To compare the risk of mortality and other clinical outcomes in children with sepsis, severe sepsis, or septic shock who received antibiotics within the first hour of recognition (early antibiotics group) with those who received antibiotics after the first hour (delayed antibiotics group).
In this prospective cohort study, we enrolled children <17 years of age presenting to the pediatric emergency and diagnosed with sepsis or septic shock without prior antibiotic therapy. Primary outcome was mortality and the secondary outcomes were day 1 Pediatric Logistic Organ Dysfunction score, ventilator-free days, and hospital-free days. These outcomes were compared between the early and the delayed antibiotic groups. The reference point for defining early and delayed antibiotic groups was time 0, which was measured from the time the patient was diagnosed to have sepsis, severe sepsis, or septic shock to the time of administration of the first dose of antibiotics.
About three-fourths (77%) of the 441 children enrolled had septic shock. A total of 241 (55%) and 200 (45%) children were in the delayed and early antibiotic groups, respectively. Children in the delayed group had significantly higher odds of mortality than those in the early group (29% vs 20%; aOR 1.83; 95% CI, 1.14-2.92; P = .01). The time to shock reversal was significantly shorter, and the ventilator-free days and hospital-free days were significantly greater, in the early antibiotic group. There was no difference between the groups with regard to any of the other clinical outcomes.
Delayed administration of antibiotics beyond 1 hour of recognition was associated with higher mortality rates in children with sepsis, severe sepsis, and septic shock. Antibiotics should be administered within the first hour, along with other resuscitative measures, in these children.
比较在识别后 1 小时内(早期抗生素组)接受抗生素治疗与 1 小时后(延迟抗生素组)接受抗生素治疗的脓毒症、严重脓毒症或脓毒性休克患儿的死亡率和其他临床结局的风险。
在这项前瞻性队列研究中,我们纳入了年龄小于 17 岁、未接受过抗生素治疗的表现为脓毒症或脓毒性休克的儿科急诊患儿。主要结局是死亡率,次要结局是第 1 天儿科 LOGO 器官功能障碍评分、无呼吸机天数和无住院天数。将这两个组的结局进行比较。早期和延迟抗生素组的定义参考点是时间 0,从患者被诊断为脓毒症、严重脓毒症或脓毒性休克开始到首次给予抗生素的时间。
大约四分之三(77%)的 441 名入组患儿患有休克。共有 241 名(55%)和 200 名(45%)患儿分别进入延迟和早期抗生素组。延迟组患儿的死亡率明显高于早期组(29% vs 20%;aOR 1.83;95%CI,1.14-2.92;P=0.01)。早期抗生素组的休克逆转时间明显更短,无呼吸机天数和无住院天数明显更长。两组在其他临床结局方面无差异。
在识别后 1 小时以上给予抗生素与脓毒症、严重脓毒症和脓毒性休克患儿的死亡率升高相关。这些患儿应在第 1 小时内给予抗生素,同时给予其他复苏措施。